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While humans are exposed to mixtures of persistent organic pollutants (POPs), their risk assessment is
usually based on a chemical-by-chemical approach. To assess the health effects associated with mixed
exposures, knowledge on mixture toxicity is required. Several POPs are potential ligands of the Aryl
hydrocarbon receptor (AhR), which involves in xenobiotic metabolism and controls many biological
pathways. This study assesses AhR agonistic and antagonistic activities of 29 POPs individually and in
mixtures by using Chemical-Activated LUciferase gene eXpression bioassays with 3 transgenic cell lines
(rat hepatoma DR-H4IIE, human hepatoma DR-Hep G2 and human mammary gland carcinoma DR-T47-
D). Among the 29 POPs, which were selected based on their abundance in Scandinavian human blood,
only 4 exerted AhR agonistic activities, while 16 were AhR antagonists in DR-H4IIE, 5 in DR-Hep G2 and 7
in DR-T47-D when tested individually. The total POP mixture revealed to be AhR antagonistic. It
antagonized EC50 TCDD inducing AhR transactivation at a concentration of 125 and 250 and 500 fold
blood levels in DR-H4IIE, DR-T47-D and DR-Hep G2, respectively, although each compound was present
at these concentrations lower than their LOEC values. Such values could occur in real-life in food
contamination incidents or in exposed populations. In DR-H4IIE, the antagonism of the total POP mixture
was due to chlorinated compounds and, in particular, to PCB-118 and PCB-138 which caused 90% of the
antagonistic activity in the POP mixture. The 16 active AhR antagonists acted additively. Their mixed
effect was predicted successfully by concentration addition or generalized concentration addition
models, rather than independent action, with only two-fold IC50 underestimation. We also attained good
predictions for the full dose-response curve of the antagonistic activity of the total POP mixture.
© 2019 Elsevier Ltd. All rights reserved.1. Introduction
The aryl hydrocarbon receptor (AhR) was originally character-
ized as a xenobiotic mediator (Hankinson, 1995). It is often called
the “dioxin receptor” as 2,3,7,8-tetrachlorodibenzo-p-dioxine by Wen Chen.
he last authors.(TCDD) and several dioxin-like (dl) compounds are AhR agonists.
Adverse health effects associated with exposure to these AhR ag-
onists are widely studied, including abnormal reproduction and
development, impaired immune system, liver toxicity and cancers
(Consultation, 2000).
AhR physiological roles have recently gained more attention
since AhR is activated by a wide range of structurally diverse
endogenous and exogenous compounds (Denison and Nagy, 2003).
Also, AhR-deficient rodents suffer from various physiological de-
fects in the immune system (Harrill et al., 2015), liver (Gonzalez and
Fernandez-Salguero, 1998), kidney (Harrill et al., 2015; Harrill et al.,
T.Q. Doan et al. / Environmental Pollution 254 (2019) 11309822013), cardio-vascular system (Lahvis et al., 2000), urinary bladder
(Butler et al., 2012), etc. Additionally, AhR homologues are pre-
served in animal evolution for 600 million years (Hahn et al., 2017),
while invertebrate AhR homologues cannot bind dioxin (Butler
et al., 2001), indicating that dioxin detection was not the primary
role of this protein. Increasing evidence supports important roles of
AhR in normal development and homeostasis, while toxicity
induced by AhR xenobiotic ligands could be due to perturbation of
these normal processes (Marlowe and Puga, 2005).
Upon ligand binding, the AhR is translocated from cytosol into
the nucleus where it joins its dimerization partner, aryl hydrocar-
bon receptor nuclear translocator (ARNT). This AhR/ARNT complex
then binds to a DNA sequence called dioxin responsive element
(DRE) to activate the expression of a battery of genes, including
both phase I and phase II xenobiotic metabolism enzymes, of which
cyp1a1 is the best characterized. Hence, methodsmeasuring cyp1a1
gene expression are widely accepted for determining AhR activa-
tion (Wall et al., 2015), among which cell-based screening methods
such as Chemical-Activated LUciferase gene eXpression (CALUX)
are the most common (Murk et al., 1996; Scippo et al., 2004;
Goeyens et al., 2010).
Many potential AhR ligands are persistent organic pollutants
(POPs). POPs are resistant to degradation and widely distributed in
the environment. They can be detected in almost every human
sample, including fetuses and embryos (Vizcaino et al., 2014). They
tend to bioaccumulate and biomagnify in living organisms, result-
ing in toxic health effects to both humans and wildlife (Convention,
1997).
Presently, chemical risk assessment mainly relies on a chemical-
by-chemical approach (Bopp et al., 2018). In real life, humans are
exposed not to an individual POP, but to highly complex POP
mixtures (Kortenkamp, 2007). Understanding mixture toxicity is
crucial to assess the potential adverse health effects associatedwith
such real life exposure to mixtures of POPs (EC COM, 2012). The
mixture effects may be additive, synergistic, or antagonistic
depending onwhether they are equal, stronger, or weaker than the
sum of the effects of individual components, respectively
(Berenbaum, 1985). The concepts called “something from nothing”
and “a lot from a little” were introduced to describe the mixture
effect (Kortenkamp et al., 2009) and proved in a study on fish when
a significant effect was observed for a mixture combining individ-
ual compounds each at “no observed effect” concentrations
(Thrupp et al., 2018).
Due to the various mixture forms and doses, models using the
information of components to predict the combined effects are
required. Three mathematical models have been developed for this
purpose: i) the concentration addition (CA) model was designed for
chemicals with similar mode of actions (MOAs) (Loewe and
Muischnek, 1926), but has also proven useful for mixtures with
dissimilar compounds (Thrupp et al., 2018; Birkhøj et al., 2004;
Orton et al., 2014); ii) independent action (IA) (Bliss, 1939), suc-
cessful in several applications (Backhaus et al., 2004; Payne et al.,
2000), applies for chemicals which act independently and have
different MOAs; and iii) the generalized concentration addition
(GCA) (Howard and Webster, 2009), a CA modified model, was
developed for predicting the effects of mixtures containing partial
agonists (Howard and Webster, 2009; Howard et al., 2010;
Brinkmann et al., 2018).
In an effort to fill the gap in the knowledge of mixture toxi-
cology, a defined mixture of 29 POPs (total POP mixture) was
constructed based on their prominence in blood and/or food and
breastmilk with the concentration being average blood values from
recent Scandinavian studies (Småstuen et al., 2010; Knutsen et al.,
2008; Polder et al., 2008) published prior to 2012 (Berntsen et al.,
2017). To mimic the exposure of cells (in a tissue) to chemicalsthat are in the blood stream, reporter gene assays involving cancer
cell lines from different tissues (liver and mammary gland) and
species (rat and human) were used in this study to determine the
AhR transcriptional activities of the selected 29 POPs, individually
and in mixtures (the total POP mixture and six sub-mixtures
(Berntsen et al., 2017)). The aims were to (a) assess both AhR
agonistic and antagonistic activities after exposing the cell lines to
the 29 POPs and to themixtures, (b) identify themain compound(s)
responsible for the observed effects of the mixtures, and (c) predict
the mixture activity by applying the three available models (IA, CA
and GCA).
2. Materials and methods
2.1. Chemicals and suppliers
The total POP and six sub-mixtures were designed and premade
by the Norwegian University of Life Sciences, Oslo, Norway as
described (Berntsen et al., 2017). The former consists of 29 POPs,
where most of them are listed as POPs under the Stockholm
Convention on Persistent Organic Pollutants, belonging to three
groups: six perfluorinated compounds (PFAAs), seven brominated
compounds (BFRs), and 16 chlorinated compounds with seven
polychlorinated biphenyls (PCBs) and nine organochlorine pesti-
cides (OCPs). The latter consist of either one single class of com-
pounds (PFAA, Br and Cl) or two combined classes (ClþBr, ClþPFAA,
BrþPFAA). This way of mixture preparationwas to enable the study
of the effect of adding or removing one chemical group on different
endpoints. As the design of the mixtures was focused on com-
pounds occurring at high concentrations, most dl-PCBs (with the
exception of PCB-118) and polychlorinated dibenzodioxins/poly-
chlorinated dibenzofurans (PCDD/PCDF) were deliberately
excluded. These compounds were also omitted due to their high
toxicity at low concentrations in several systems to allow the study
of the effect of the non-dl and most prevalent compounds. The
components included in the mixtures and their respective con-
centrations are given in Table S1.
Along with the mixture testing, 29 POPs from the total POP
mixture were also examined individually. They were bought from
Sigma Aldrich (Missouri, USA) except o-chlordane from Toronto
Research Chemicals (North York, Canada) and PCB-118 from Dr
Ehrenstorfer (Augsburg, Germany). All chemicals were dissolved in
dimethylsulfoxide (DMSO) (Acros Organics, Molinons, France),
except HCB in hexane (Merck, Massachusetts, USA).
The 29 individual POPs and the mixtures were stored as stock
solutions at 20 C. Working solutions were prepared from the
stock solutions to reach the concentrations mentioned in Table S1.
The highest tested concentration was 50 mM for all PCBs and PFAAs
and 20 mM for BFRs except BDE-100, BDE-153, BDE-154 and BDE-
209 (1 mM) due to stocks available. OCPs were tested at the
maximum concentration of 100 mM for g-HCH and dieldrin, or
80 mM for all the others. The concentrations for mixture exposure
are presented as “fold blood levels”, relative to the average
contaminant levels found in human blood of the Scandinavian
population. The total POP mixture and sub-mixtures were tested at
concentrations between the estimated concentrations in human
blood and maximum 3000 fold blood levels.
2.2. Determination of aryl hydrocarbon receptor agonistic and
antagonistic activities
2.2.1. Cell-based assays
Rat and human dioxin responsive (DR) cell lines were used. Rat
hepatoma DR-H4IIE cells were from BioDetection System
(Amsterdam, The Netherlands) while both human cell lines
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were previously home-made (Liege, Belgium) (Van der Heiden
et al., 2009). A vector containing an AhR-controlled luciferase re-
porter gene was stably integrated into these cells. The vector in-
tegrated into DR-H4IIE cells contained four native DREs (from the
upstream promotor of the mouse cyp1a1 gene), leading the MMTV
(Mouse Mammary Tumour Virus) promoter (Garrison et al., 1996),
while both DR-T47-D and DR-Hep G2 cells were transfected with a
vector containing four synthetic DREs regulating the thymidine
kinase promoter (Van der Heiden et al., 2009). The cells were
routinely cultured in MEMa (Thermo Fisher Scientific, Massachu-
setts, USA) supplemented with 10% v/v fetal bovine serum (Greiner,
Kremsmünster, Austria), 50 IU/mL penicillin and 50 mg/mL strep-
tomycin (Sigma Aldrich, Missouri, USA), and incubated in a H20
saturated atmosphere containing 5% CO2, at 37 C.
The methodology for the DR-CALUX (Dioxin Responsive
Chemical-Activated LUciferase gene eXpression) bioassays was
described in detail elsewhere (Van der Heiden et al., 2009; Scippo
et al., 2005). Briefly, cells were first seeded in white clear-
bottomed 96 well microplates (Greiner, Kremsmünster, Austria)
and incubated for 24 h to reach about 90% of confluence in the well.
After 24-h exposure, the cells were washed with phosphate buff-
ered saline (Sigma Aldrich, Missouri, USA) and treated with lysis
solution (containing Triton X100, Sigma Aldrich, Missouri, USA).
Luciferin (Promega, Wisconsin, USA) and ATP (Roche Diagnostics,
Rotkreuz, Switzerland) were then added to the cell lysate to pro-
duce luminescence, which was measured by using a luminometer
(ORION II, Berthold Detection System, Pforzheim, Germany). The
cells were exposed, in triplicates, to a dilution series of the tested
compound/mixture in both agonistic and antagonistic tests. For the
latter, the cells were co-exposed with a constant concentration of
15 pM, 150 pM and 650 pM TCDD corresponding to TCDD EC50 in
DR-H4IIE, DR-T47-D and DR-Hep G2 cells, respectively.
In order to verify whether AhR antagonists compete for the
same, single site on the AhR with the agonist (TCDD), additional
antagonistic tests were performed for selected compounds by co-
exposing DR-H4IIE cells to different concentrations of the tested
compounds and a constant saturating TCDD concentration (20 nM).
Using the agonist (TCDD) at clearly saturating concentrations
would make it impossible for a lower affinity antagonist to affect
transcriptional activation at all.
All the exposure experiments were repeated at least three times
independently. The final concentration of DMSO in the culture
medium for the single POPs was 0.2% and 0.3% for agonistic and
antagonistic tests, respectively, while they were 0.3% and 0.4% for
the mixtures. For quality control, a TCDD reference curve was
performed on each plate.
MTT cell viability and LDH cell cytotoxicity were performed
along with visual inspection of cell morphology and attachment.
The former was carried out in a replicate plate to the DR-CALUX
assays. After 24-h exposure, 25 mL MTT dye solution (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 5mg/ml,
Sigma Aldrich, Missouri, USA) was added into each well, followed
by a 4-h incubation at 37 C to form insoluble purple formazan.
Then, 100 mL isopropanol (Merck, Massachusetts, USA) was added
into the plates to dissolve the formazan for 2 h. The MTT formazan
absorbance was read at 550/630 nm by a spectrophotometer
(ELx800™ BioTek, Winooski, USA). Because the MTT data need to
be interpreted with caution and are not necessarily related to cell
death, we performed the LDH cell cytotoxicity as well. The Pierce™
LDH Cytotoxicity Assay Kit was purchased from Thermo Fisher
Scientific (Massachusetts, USA) and operated according to the
manufacturer's instructions (absorbance at 490/630 nm).2.2.2. Calculations of EC50, IC50 and efficacy (RPCMax)
Final results were presented as relative responses, i.e. percent-
ages of the cell response to the tested compound/mixture
compared to the maximum response of the cells to TCDD on the
same plate for agonistic activities, or to spike-in TCDD EC50 for
antagonistic activities. Dose-response curves were generated by
Graphpad PRISM software, version 7 (San Diego, California, USA) by
fitting a four-parameter non-linear regression for agonistic (Eq. (1))











where x is the concentration of a tested compound/mixture
inducing the relative response Yagonistic or Yantagonistic. EC50 and IC50
are the half maximal effective concentration for an agonist and
antagonist, respectively (OECD, 2016). B¼ bottom, T¼ Top, H ¼
Hillslope.
The lowest observed effect concentration (LOEC) is the lowest
tested concentration at which a significant effect (p< 0.05) was
observed. The maximum observed effect concentration (MOEC) is
the lowest tested concentration causing the maximum effect
(p< 0.05). ANOVA (Graphpad PRISM) was used to determine sta-
tistical significance. Prior to ANOVA, tests for homogeneity of
variance and normal distribution (transformation if needed) were
performed. When no full dose-response curve was achieved, MOEC
was considered as the highest concentration of the test series. Ef-
ficacy was determined as RPCMax (%), which is the maximum effect
induced by the tested compound (OECD, 2016): AhR agonistic
RPCMax was the maximum relative response of the compound/
mixture compared to the maximum TCDD response, while AhR
antagonistic RPCMax was the minimum relative response observed
by the maximum inhibition of the test compound/mixture to the
spike-in TCDD EC50. The compound/mixture was accepted as active
when its relative response was higher than the threshold level
RPCMax  10% for AhR agonists and lower than RPCMax  70% for
AhR antagonists (OECD, 2016).2.2.3. Calculations of the predicted mixture antagonistic effects
2.2.3.1. Concentration addition (CA). CA model is based on a dilu-
tion principle, all the chemicals behave as they are simply the
dilution of one another in the mixture. Hence, the effect contri-
bution of one compound to the mixture effect can be totally or
partially replaced by the effect of the other. It calculates the effect
concentration (ICmix,j) of the mixture inducing a specific antago-
nistic effect j (from 1% to 100%) by considering the concentration
partition (pi) of compound i and its respective effect concentration
(ICij) inducing the same effect j (Eq. (3)). Previously published
formulae were adapted (Loewe and Muischnek, 1926; Birkhøj et al.,








The concentration partition pi can either consider or not the
non-active (NA) compounds. Because nonactive compounds do not
give ICij, n is the number of the active compounds.
For each compound i, ICij inducing the effect j is calculated using
its ICi,50 and hillslope (Hi) from their fitted curves using Eq. (4)
(Graphpad PRISM):






Because the CA model allows only the calculation of ICmix,j, to
generate the full dose-response curves, we proposed several
possible methods to calculate the hillslope and bottom (Hmix and
Bmix) of the mixture response, while the top was set to 100% as no
response.
- the Weighted Mean Hillslope and Bottom (WMHB) (Eq. (5a))
considering pi to weight the hillslope and bottom of the indi-
vidual compounds:














- the Averaged Hillslope and Bottom (AvBH) considering the










- the Formulated Hillslope and Bottom (FoBH) (Eq. (5c)) using the
formulae of the CA:











(5c)2.2.3.2. Independent action (IA). This method assumes that the ef-
fect of each component is an independent event (Bliss, 1939). Thus,
the probability to exert a specific effect of the mixture is the joint
probability of the effect of each compound applied independently.
For calculating the relative response of the mixture, the data for
individual compounds were converted into a probability.
An antagonistic effect induced by compound i is obtained by
subtracting the measured relative response (Rik) from 100% (100%
being the relative response of TCDD EC50) and then converted into a
probability (scale 0e1, by dividing by 100). The relative response of
the mixture (0%e100%) is calculated from the combination of in-












At a specific concentration k, Rmix,k is the relative response of the
mixture; Rik is the relative response of compound i at that con-
centration k of the mixture, n is the number of the active
components.2.2.3.3. Generalized concentration addition (GCA). GCA (Eq. (7))
assumes that the hillslope for each component is equal to 1 and
considers also their RPCMax31 . It was adapted for AhR antagonistic





1þ Pni¼1 CikIC50i (7)
where Rmix,k is the relative response of the mixture at a specific
concentration k, Cik is the concentration of compound i in the
mixture at that specific mixture concentration k. RPCMax,i is the
maximum effect of compound i and IC50i is the IC50 of compound i.3. Results
In DR-H4IIE cells, while a-chlordane caused cytotoxicity at the
highest tested concentration of 80 mM, t-nonachlor already did at
62.5 mM in three cytotoxicity tests (data not shown). Theywere also
cytotoxic for the DR-T47-D at lower concentrations of 30 and
30.5 mM, respectively. These cytotoxic concentrations were
excluded from the data analyses. None of the other compounds or
mixtures induced cytotoxicity at any tested concentration.3.1. Aryl hydrocarbon receptor activities of the 29 POPs
3.1.1. AhR e mediated agonistic activities
Only four out of the 29 tested POPs presented AhR agonistic
activities (RPCMax 10%). BDE-153, PCB-138, and PCB-118 were
active in DR-H4IIE, while BDE-99 was active in DR-T47-D. BDE-99
and BDE-154 were able to trigger a weak agonistic activity
(5%< RPCMax< 10%) in DR-H4IIE, as well as g-HCH in DR-T47-D
(Table S2). No agonistic response was recorded in DR-Hep G2
cells for any of the 29 POPs.3.1.2. AhR e mediated antagonistic activities
Sixteen out of the 29 individually tested POPs displayed AhR
antagonisms. No antagonistic activities were observed for any of
the PFAAs in all three cell lines. In contrast, in DR-H4IIE cells, AhR
antagonistic responses were recorded for 16 POPs including all
PCBs, most of the OCPs (except p,p’-DDE, a-HCH and b-HCH), and
three out of the seven BRFs (BDE-47, BDE-99 and HCBD) (Table 1).
PCB-118 and PCB-138 displayed a V-shaped dose-response curve,
switching from antagonistic to agonist behavior at concentrations
above 3.5 mM and 27.5 mM, respectively. Hence, their IC50 values
were determined by only the antagonistic part of the curve. The
dose-response curves obtained from DR-H4IIE cells co-exposed to
TCDD EC50 and the 16 AhR antagonistic POPs are shown in Fig. S1
(solid lines) with a detail in Table S3.
DR-Hep G2 cells were less responsive to the POPs than DR-H4IIE,
with only five compounds exerting antagonistic activities, namely
PCB-28, PCB-118, PCB-138, HCB and BDE-47 (Table 1). PCB-28 was
the most potent compound, almost completely abolishing the ac-
tivity of 650 pM TCDD in DR-Hep G2, displaying an RPCMax of
7.2± 3.6% and an IC50 of 6.1± 1.4 mM. In DR-T47-D cells, seven out of
the 29 POPs showed AhR antagonistic activities (PCB-28, PCB-118,
PCB-138, HCB, a-chlordane, t-nonachlor and g-HCH). The highest
potencies were found for a-chlordane and t-nonachlor with RPCMax
of 7.4± 12.5% and 27.8± 3.5%, respectively.3.1.3. Evaluating competitive inhibition of 16 antagonists in DR-
H4IIE
The AhR antagonistic activities were abolished for all com-
pounds (except a-chlordane and t-nonachlor with RPCMax of 56.6%
and 56.8%, respectively) when co-exposing with excessive 20 nM
TCDD, indicating they are possible AhR competitive antagonists
(Fig. S1, dashed lines).
Table 1
AhR antagonistic responses (LOEC, MOEC, IC50 and RPCMax) of 16 POPs in DR-H4IIE, DR-Hep G2 and DR-T47-D cell lines (n¼ 3, 0.3% DMSO).
Compounds DR-H4IIE DR-Hep G2 DR-T47-D
LOEC (mM) MOEC (mM) IC50± SE (mM) RPCMax (%) LOEC (mM) MOEC (mM) IC50± SE (mM) RPCMax (%) LOEC (mM) MOEC (mM) IC50± SE (mM) RPCMax (%)
PCB-28 2.5 25 6.8± 1.7 36.6± 4.3 2.5 25 6.1± 1.4 7.2± 3.6 3.5 25 11.4± 1.5 48.3± 5.9
PCB-52 2.5 50* 7.3± 1.2 17.1± 5.5 e e e e e e e e
PCB-101 12.5 50* 17.9± 3.8 54.3± 3.6 e e e e e e e e
PCB-118 0.5 2.5 0.3± 0.05 67± 4.7 12.5 25 9± 2.7 38.3± 16.5 12.5 27.5 13.6± 2.4 49.2± 4.9
PCB-138 0.5 2.5 0.6± 0.07 42.8± 2.8 3.5 25 ND 50.2± 9.5 12.5 50* ND 42.6± 2.5
PCB-153 0.01 50* 18.5± 2.8 16.7± 4.6 e e e e e e e e
PCB-180 1 50* 7.4± 3.3 16± 1.4 e e e e e e e e
HCB 0.075 37.5 17.9± 11.6 42± 8.7 3.75 37.5 4.5± 2.3 39.4± 12.7 0.075 30 16.4± 2.1 51.7± 6.7
a-Chlordane 0.4 50* 28.3± 3.3 15± 1.1 e e e e 10 30 20.2± 2.1 7.4± 12.5
ο-chlordane 20 40* 26.5± 19.4 26.3± 1.5 e e e e e e e e
t-nonachlor 25 50* 34.3± 1.8 34.2± 8.1 e e e e 25 25 16.8± 2 27.8± 3.5
g-HCH 0.5 50 27.5± 2.7 40.7± 3.5 e e e e 50 75 61.2± 2.9 65.4± 13.7
Dieldrin 6.25 50 22.4± 11.4 59.6± 1.9 e e e e e e e e
BDE-47 0.25 20* 3.1± 0.5 17.9± 2.7 1.25 12.5 ND 55.3± 7.2 e e e e
BDE-99 0.25 10 5.2± 1.9 36.3± 1.5 e e e e e e e e
HBCD 0.25 15 35.8 ± 63.9** 58.1± 3.1 e e e e e e e e
LOEC: lowest observed effect concentration (p< 0.05); MOEC: maximum observed effect concentration (p< 0.05); IC50: the concentration inducing half of the maximum
inhibition response; SE: Standard Error; RPCMax: observed efficacy expressed as a percentage of the cell response exposed to 15 pM, 650 pM and 150 pM TCDD, respectively for
DR-H4IIE, DR-Hep G2 and DR-T47-D, corresponding to the MOEC; ND: Not Determined. * Corresponds to the highest tested concentration. ** IC50 estimated beyond tested
concentrations. -: no response.
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3.2.1. AhR e mediated agonistic activities
Exposure to the total POP mixture or to the six sub-mixtures
described in Table S1 did not induce any significant
(RPCMax 10%) AhR agonistic response in any of the cell lines (data
not shown), as it could be expected with the exclusion of dl-PCBs
and PCDD/F.
3.2.2. AhR e mediated antagonistic activities
The total POPmixture triggered an AhR antagonistic response in
all cell lines (Table 2, Fig. 1A). At a concentration in the culture
medium corresponding to the blood level, the total POPmixture did
not interfere with the response of the cells to EC50 TCDD. In
contrast, significant and dose-dependent antagonistic responses
were already observed at concentrations of 125, 250 and 500 fold
blood levels, respectively, for DR-H4IIE, DR-T47-D and DR-Hep G2,
although the concentrations of all 29 compounds were below their
respective LOEC at these levels or even at 1000 fold blood levels
(Table S1). In DR-H4IIE, the POP mixture displayed a significantly
high AhR antagonistic efficacy of 52.5± 2.1% at 1000 fold blood
levels and an IC50¼ 374± 52 fold blood levels, while in both human
cell lines, a significant response was observed, but did not reach
below 80%, making the calculation of an IC50 not possible.
In parallel, six complementary sub-mixtures (PFAA, Br, Cl, ClþBr,
ClþPFAA, BrþPFAA) were also tested to study the possible in-
teractions between these groups of compounds. Antagonism was
seen for all Cl containing mixtures (the total POP, Cl, ClþBr andTable 2
AhR antagonistic responses (LOEC, MOEC, IC50 and RPCMax) of the total POPmixture and Cl
cells (n ¼ 3, 0.4% DMSO).
Mixtures DR-H4IIE DR-Hep G2
LOEC (x bl) MOEC (x bl) IC50± SE (x bl) RPCMax (%) LOEC (x bl) MOEC (x bl
POP 125 1000 374± 52 52.5± 2.1 500 1000
Cl 250 1000 562± 54 53± 0.9 250 2000
ClþBr 125 2000 468± 38 64.6± 1.7 500 1000
ClþPFAA 75 2000 461± 78 41± 1.3 500 500
LOEC: lowest observed effect concentration (p< 0.05); MOEC: maximum observed effe
inhibition response; SE: Standard Error; RPCMax: relative response at MOEC expressed in %
H4IIE, DR-Hep G2 and DR-T47-D) corresponding to the MOEC; x bl: fold blood levels; NClþPFAA mixtures) in DR-H4IIE and DR-Hep G2, while only the
total POP and ClþPFAA mixtures showed responses in DR-T47-D
(Table 2).
In DR-H4IIE cells, the three Cl containing sub-mixtures and the
total POP mixture gave more or less similar responses with
IC50y 400e500 fold blood levels and RPCMax y 50%. This indicates
that the chlorinated compounds were responsible for the antago-
nism of all mixtures where they are present. Also, the antagonistic
response curve of ClþPFAA mixture overlapped that of the total
POP mixture, which placed below those of the Cl and ClþBr
(Fig. 1B). These observations suggest that the effect of the Cl
mixture was somehow enhanced in the ClþPFAAmixture, resulting
in a dose-response curve overlapping that of the total POP mixture.
3.3. Predictions of the rat aryl hydrocarbon receptor antagonistic
activities of the total POP mixture and Cl containing sub-mixtures
We evaluated the capacity of the three different mathematical
models (concentration addition (CA), independent action (IA), and
generalized concentration addition (GCA)) to predict the IC50 and
dose-response curves of the total POPmixture in the most sensitive
cell line, the DR-H4IIE.
3.3.1. Calculation of bottom and hillslope values
Because the 16 rat AhR antagonists contributed only 4.3% for the
mass of the total POP mixture, along with considering all of the 29
POPs to calculating pi, we also considered only the active com-
pounds, subtracting the weight of the non-active compounds (sNA)containing sub-mixtures (Cl, ClþBr, ClþPFAA) in DR-H4IIE, DR-T47-D and DR-Hep G2
DR-T47-D
) IC50± SE (x bl) RPCMax (%) LOEC (x bl) MOEC (x bl) IC50± SE (x bl) RPCMax (%)
ND 80.1± 5.8 250 1000 ND 86.6± 2.2
ND 59± 1.6 e e e e
534± 253 76.1± 3.9 e e e e
243± 104 77± 3.8 500 500 ND 77± 3.8
ct concentration (p< 0.05); IC50: the concentration inducing half of the maximum
of the response of TCDD EC50 15 pM, 650 pM and 150 pM TCDD (respectively for DR-
D: Not Determined. -: no response.
Fig. 1. (A) Dose-response curves obtained from DR-H4IIE, DR-T47-D and DR-HepG2
cells co-exposed to 15 pM, 150 pM and 650 pM TCDD, respectively, and the total
POP mixture. (B) Dose-response curves obtained from DR-H4IIE cells co-exposed to 15
pM TCDD, and the total POP mixture, or the Cl, ClþBr and ClþPFAA sub-mixtures
(Mean ± SD, n ¼ 3, 0.4% DMSO).
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dict both bottom and hillslope values. AvBH and FoBH showed
reasonable predicted values, especially AvBH and sNA FoBH for the
total POP mixture and the three Cl containing sub-mixtures
(Table S4).3.3.2. Prediction of mixture effects of the three models
The results obtained after running the three models are shown
in Fig. 2. While the IA predicted a really strong response even at the
lowest concentrations of the mixture, far out of the range of the
measured curve, both the CA (CA-AvBH and CA-sNA FoBH) and GCA
predictions resulted in calculated curves comparable to the
measured curve. This refers that the 16 active compounds in the
total POP mixture acted additively rather than independently.
The measured IC50 of the total POP mixture (374± 52 fold blood
levels) was lower than the predicted value (784 fold blood levels for
both the GCA and CA models), while the IA model predicted
IC50¼ 2153 fold blood levels. Thus, both CA and GCA models
underestimated IC50 of the total POP mixture by about two folds,much less than one order of magnitude.
Concerning the calculated dose-response curves, the two addi-
tive models appeared to diverge: GCA produced a somewhat better
prediction in the low concentration range, both CA (CA-AvBH and
CA-sNA FoBH) closely followed the experimental curve and only
diverged at concentrations higher than around 1000 fold blood
levels (Fig. 2). Similar predictions were also shown for the three
active Cl, ClþBr, ClþPFAA sub-mixtures (Table S4, Fig. S2).3.3.3. Toxic units
Derived from CA model, toxic units (i.e. the ratio of the con-
centration partition of a compound to its IC50 (pi/IC50,i)) scales the
concentrations of the mixture components to its toxicity, repre-
sented by the transcriptional activity of the Cyp1a1 promotor. Thus,
it has been applied to identify the main driver(s) for mixture effects
in CA model (Loewe and Muischnek, 1926; Backhaus et al., 2004;
Evans et al., 2012). Fig. 3A clearly shows that PCB-138 and PCB-118
were the twomain contributors for the AhR antagonism of the total
POP mixture, constituting to 90% of the total combined activity.
Since theywere also partial agonists, it is likely that, in the presence
of TCDD, they behaved mainly as antagonists especially at low
concentrations. Following this prediction, a binary mixture of PCB-
138 and PCB-118 was generated according to their concentration in
the total POP mixture. The dose-response curve of this mixture
followed that of the total POP mixture very closely, with an IC50 of
505± 67 fold blood levels (while IC50¼ 374± 52 fold blood levels
for the total POP mixture) (Fig. 3B).4. Discussion
4.1. AhR transactivation activities of the 29 POPs and the mixtures
This study shows that amajority of the chemicals composing the
realistic total POP mixture are actually AhR antagonists (16 in DR-
H4IIE, five in DR-Hep G2 and seven in DR-T47-D cells). As ex-
pected, the total POP mixture and the Cl containing mixtures were
also shown to be antagonistic. These activities were AhR-
dependent, and seemed to act through competition for the TCDD
binding site, except for t-nonachlor and a-chlordane.
In our study, we tested the AhR transcriptional activity of POPs
and POP mixtures using a transcriptional reporter assay, which
basically reports the canonical AhR-driven pathways via AhR-
ARNT-DRE interactions. However, we observed that two of the
compounds (a-chlordane and t-nonachlor) do not seem to exert
their antagonistic effect through competitive binding to AhR.
Several possible non-canonical AhR-driven pathways could
contribute to the observed results, such as crosstalk with other
nuclear receptors, regulation of cell cycle and MAP kinase cascades,
or novel AhR DNA-binding partners (Wright et al., 2017; Jaeger and
Tischkau, 2016). Further studies of these mechanisms are required,
but were outside of the scope of this paper.
Our results concerning single compound testing are in general
consistent with previously published studies, where available. For
agonistic activity, PCB-118 displayed highest RPCMax¼ 61.3% at
50 mM, with EC50¼ 25± 13 mM similar to previously finding
(9.3± 2.5 mM) (Brenerova et al., 2016). EC50¼ 4± 0.8 mM of BDE-99
was lower than previous report (EC50> 15 mM) (Hamers et al.,
2006). For PCB-138, we observed an agonistic effect with a high
EC50¼ 28 ± 6.4 mM, which was not reported before (Brenerova
et al., 2016) (Table S2).
For antagonistic activities, in this study, IC50 of PCB-28 and PCB-
138 were 6.8± 1.7 and 0.6± 0.07 mM (Table 1), close to previous
estimates of 9.0± 2.9 mM and 1.4± 0.1 mM, respectively (Brenerova
et al., 2016). BDE-47 activity (IC50¼ 3.1± 0.5 mM) was similar to
Fig. 2. Measured and predicted dose-response curves obtained from rat DR-H4IIE cells co-exposed to 15 pM TCDD and the total POP mixture, and from three prediction models.
CA ¼ Concentration addition, IA ¼ Independent action, GCA¼Generalized concentration addition, AvBH¼ averaged hillslope and bottom, and sNA FoBH¼ subtracted nonactive
compounds, formulated hillslope and bottom. Green dashed lines represent the 95% confidence interval of the measured response.
Fig. 3. (A) Distribution of toxic units of the 16 active AhR antagonists. (B) Dose-
response curves obtained from rat DR-H4IIE cells co-exposed to 15 pM TCDD and
the total POP mixture or a binary mixture consisting of PCB-138 and PCB-118
(Mean ± SD, n¼ 3, 0.4% DMSO).
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(3.7± 0.8 mM) (Brenerova et al., 2016). However, the
IC50¼ 5.2± 1.9 mM for BDE-99 found in this study was lower than
that previously reported (13± 0 mM) (Hamers et al., 2006). This
study reports for the first-time data for the AhR transcriptional
activity of the 29 POPs in both human mammary gland carcinoma
DR-T47-D and hepatoma DR-Hep G2 cells.
Differences between IC50 or EC50 values of this study and those
from previous findings (Brenerova et al., 2016; Hamers et al., 2006)
may result from differences in the experimental design and the
regression methods (i.e. the number of concentration points,
availability of a maximum effect if a full curve is generated,
extrapolation if the maximum effect is not reached, and the
regression function used with either four or three parameters). Our
study not only confirms and consolidates previous findings
(Brenerova et al., 2016; Hamers et al., 2006), but it also contributes
new data including full dose-response curves with four parameter
fit (see Table S3) which can be used for further data treatment or
calculation of the joint effect of any mixture made from these 29
POPs for the rat DR-H4IIE cells.
We observed species and tissue differences in the AhR tran-
scriptional activities of the individual POPs and of the mixtures. In
general, the rat DR-H4IIE cells were more sensitive than the two
human cells towards the effects on AhR transactivation when
exposed to individual POPs or POPmixtures. Several considerations
may explain this result. Interspecies differences in AhR structure
will obviously shape the sensitivity. Rats are 1000 folds more sen-
sitive to TCDD than guinea pigs (Hulme and Trevethick, 2010).
Mouse AhR has a higher affinity than human AhR due to the
different position of the important amino acid Valine (V381 in
humans corresponding to V375 in mice) (Ramadoss and Perdew,
2004). Human AhR has shown a higher relative affinity for
certain structurally compounds i.e. endogenous ligands or poly-
phenols (Flaveny et al., 2009). Moreover, the difference in genetic
modification (origins of the integrated promotor and DREs) of the
rat DR-H4IIE compared to the two human cell lines could also play a
role for the specific responses. Differences in regulatory processes
downstream of AhR binding may be responsible, such as differen-
tial binding to transcriptional coactivators (Flaveny et al., 2008).
Finally, in the antagonistic tests, the POPs have to compete with
increasing TCDD concentration (15 pM, 150 pM and 650 pM,
respectively for DR-H4IIE, DR-T47-D and DR-Hep G2), which could
lead to the lower sensitivity to detect an antagonistic activity of the
POPs in the two human cells compared to the rat cells.
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activation
The most striking result of this study is that the total mixture of
29 POPs, derived from concentrations found in the blood of a
Scandinavian population, and sub-mixtures thereof were found to
exert only antagonistic effects on AhR. This observation is consis-
tent with our results obtained from testing each compound alone,
revealing amajority of antagonistic compounds. AhR antagonism of
POPs has been observed in several screening studies (Brenerova
et al., 2016; Hamers et al., 2006) and mixture studies (Harper
et al., 1995; Long et al., 2007). However, while the AhR agonistic
activity of POPs has been studied for decades, the antagonistic
counterpart has not yet received much attention, especially
regarding its physiological consequences on an organism's health.
This finding challenges the method of using toxic equivalency
factors (TEFs) and toxic equivalent quantities (TEQ) for risk as-
sessments of mixtures of AhR ligands. The World Health Organi-
zation assigned TEFs for PCDDs/PCDFs/dl-PCBs, expressed as
relative effect potencies compared to the most toxic form TCDD.
Regarding their additive mechanism, TEFs are also used to estimate
TEQ for a mixture of compounds by adding up the TEF fraction and
the concentration of each compound within the mixture (Van den
Berg et al., 2006). However, PCB mixtures alone or in combination
with PCDDs/PCDFs (usually TCDD) have shown additive but also
non-additive responses (Safe, 1998; Safe, 1997). Also, several envi-
ronmentally abundant biphenyls antagonize the cyp1a1 induction
by TCDD (Wall et al., 2015), while some dl-mono-ortho-substituted
PCBs revealed both agonistic and antagonistic properties (Clemons
et al., 1998; Hestermann et al., 2000). In many environmental
samples, the ratio between PCBs and AhR agonists is above 1000,
indicating that antagonisms, resulting from interactions between
AhR agonists and PCBs (Fiedler, 2003), are not irrelevant. Therefore,
the antagonistic effect of these compounds should be also consid-
ered to calculate the effect of mixtures. Since they are more
abundant in real-life mixtures, their antagonisms may undermine
or even abolish the overall dioxin potency of the environmental
mixtures (Wall et al., 2015).
Our finding also raises the issue of the biological significance of a
predominantly AhR antagonistic mixture in the blood of a human
population. We found antagonistic activities at levels of 125 fold
blood levels in rat liver cells or 250 or 500 folds in human mam-
mary gland and liver cells, levels that may realistically be reached
after an accident or in exposed populations.
It is important to note that in the total POP mixture used here
(Berntsen et al., 2017), no dioxins and dl-compounds were
included. That allows us to study the antagonism of the human-
exposure relevant POP mixtures by isolating them from the
dioxin and dl-compounds. But the roles of the dioxin and dl-
compounds in human exposure should have also been consid-
ered. Therefore, we attempted to estimate the effect of the total POP
mixture in a real-life situation. According to Kvalem et al. (2009),
the median of dl-compounds in Norwegian human blood was
33.1 pg TEQ/g lipid, which is equal to 0.6 pM in blood assuming that
blood contains 0.6% fat and 1ml blood¼ 1 g. Thus, the respective
LOECs (for the POP mixture AhR antagonistic activity) in DR-H4IIE,
DR-T47-D and DR-Hep G2 of 125, 250, and 500 fold human blood
level correspond to 75 pM, 150 pM and 300 pM of dl-compounds,
respectively. This concentration is close to the TCDD EC50 (15 pM
TCDD in DR-H4IIE, 150 pM in DR-T47-D and 650 pM in DR-Hep G2
cells) used in our antagonistic assays. Therefore, it is likely that the
total POP mixture would antagonize the activity of these dl-
compounds in the Scandinavian population.
Furthermore, the question arises whether an overall AhRantagonistic exposure would actually cause health problems by
interfering with the normal AhR function. Increasing evidence
suggests that endogenous AhR ligands exist (Rannug et al., 1987;
Rannug and Rannug, 2018), complemented by dietary
phytochemical-derived AhR agonists/antagonists (Powell and
Ghotbaddini, 2014; Jin et al., 2018). AhR induced functions are
essential for a variety of normal physiological functions. In mam-
mary tissue, AhR likely plays a physiological role in coordinating
development, differentiation, cell growth, and signaling of hor-
mones (Hubbard et al., 2018; Quintana et al., 2008; Roman et al.,
2018; Casado, 2016; Hushka et al., 1998). Knock out mice or mice
with low affinity AhR variants display impaired survival, growth,
fertility, liver function and innate and adaptive immunity (Larigot
et al., 2018). It is thus conceivable that the presence of highly sta-
ble POPs may interfere with the essential function of AhR
controlled by mostly short-lived endogenous and dietary ligands,
and thus impair cellular AhR mediated processes. The risk caused
by AhR antagonism as the major effect of POPs could well exceed
that due to their agonistic effect, however the health effect asso-
ciated to AhR antagonism is unclear and deserves further
investigation.
4.3. Predictions of mixture effects
Risk assessment for mixture exposure is crucial to protect the
health of both humans and wildlife. The individual chemical
approach underestimates the mixture exposure and decreases the
accuracy of risk assessment (Kortenkamp et al., 2009; Thrupp et al.,
2018; Silva et al., 2002). In addition, the risk of exposure to multiple
chemicals at doses below their threshold, which is the most com-
mon case in real-life, should not be underestimated or assumed as
no-effect.
In this study, the best prediction results were obtained using the
CA (concentration addition) and GCA (generalized concentration
addition) models. They performed well in predicting ICmix,50¼ 784
fold blood levels within two folds from the measured value (374
fold blood levels). This is considered as well accepted in predicting
the combined effect of complex mixtures i.e. the total POP mixture
with its components present at low concentration (lower than their
LOECs at 1000 fold blood levels) and belonging to different com-
pound groups.
CA is often chosen as the default model (Hardy et al., 2018) for
predicting mixture activities, first for mixtures with similar com-
pounds (Loewe and Muischnek, 1926) then expended to dissimilar
compounds (Thrupp et al., 2018; Birkhøj et al., 2004; Orton et al.,
2014). Previous studies have shown the capability of the CA
model to predict the mixture effect using the information of indi-
vidual chemicals obtained in vitro (Birkhøj et al., 2004; Evans et al.,
2012; Ghisari et al., 2015; Liu et al., 2015), ex vivo (Gaudriault et al.,
2017) or in vivo (Thrupp et al., 2018; Birkhøj et al., 2004). In vitro
research has mainly focused on an equimolar mixture with less
than ten components and at high exposure concentrations. Birkhøj
et al. (2004) successfully applied the CA model to predict the
antiandrogenic effect of amixture of five commonly used pesticides
at 10 mM each. In contrast, the CA model was unable to predict the
effect on thyroid hormone function and AhR transactivation of
another mixture of five different pesticides at the maximum con-
centration of 50 mM each, due to the presence of an inhibitory
compound (Ghisari et al., 2015). Other studies focused on more
complex mixtures with multiple components at lower doses,
typically below their threshold doses, or on human or environ-
mentally relevant exposure scenarios. Two complex mixtures of 17
estrogenic chemicals were screened for estrogenic activities,
reporter-gene (ERLUX) and cell proliferation (ESCREEN) endpoints
(Evans et al., 2012). This represents one of the most comprehensive
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the effects of the two mixtures.
GCA, on the other hand, has been recently developed and
proven useful specifically for calculating mixtures containing par-
tial agonists (Howard and Webster, 2009; Howard et al., 2010;
Brinkmann et al., 2018), but has not been applied before to calculate
the activity of AhR antagonists. It allows to consider theoretically
the fact that some agonists never reach the full activity of TCDD, or
that some antagonists present partial agonistic activities.
The difference between CA and GCA models resides in the
predicted dose-response curve of the mixture and in the maximum
predicted activity of the total POP mixture (Fig. 2). GCA predicting
the mixture response, allows to generate the full dose-response
curve of the mixture using only the data from testing the individ-
ual compounds (i.e. RPCMax, concentration and IC50). The reason
why this predicted curve diverged from the experimental curve at
higher concentrations could result from the assumption that the
hillslopes of all components, and so of the POPmixture, are equal to
1, which is clearly not the case (Table S3). However, GCA predicted
the bottom (RPCMax¼ 52%) very close to the observed value for the
total POP mixture (52.5%) thanks to its consideration of the RPCMax.
On the other hand, CA provides a prediction of ICmix,j without
the full dose-response curve. Therefore, we calculated the hillslope
and the bottom values for the mixture response based on its
components by formulating several possibilities. The dose-
response curve generated by CA with averaged bottom hillslope
(CA-AvBH) resulted in the best fit with reasonable hillslope and
bottom values (1.7 and 21%) compared to 1.3 and 52.5%, respec-
tively of the measured POP mixture curve. Subtracted non-
activated compounds and formulated bottom hillslope (sNA
FoBH) predicted an overlapped curve with the observed up to 1000
fold blood levels because of its closer Hmix¼ 1.5, but overestimated
the extension of antagonism at higher concentration, leading to the
prediction of Bmix¼ 0% for the total POP mixture. Bmix is important
when predicting the activity of a mixture for risk assessment.
Therefore, CA-AvBH rather than CA-sNA FoBHwas chosen as amore
suitable prediction in our case. The CA model also provides a good
prediction of ICmix,50 for the response of the DR-H4IIE cells to the
active sub-mixtures as to the total POP mixture, and reasonable
predicted dose-response curves (Table S4, Fig. S2).
Finally, IA (independent action) was designed specifically for
mixtures of compounds with clearly different MOAs to combine
probabilities of action of individual compounds. Previous studies
showed that IA outperformed CA (Thrupp et al., 2018) or was
comparable to CA with equal (Payne et al., 2000) or not more than
five-fold differences (Backhaus et al., 2004; Faust et al., 2003) in
predicting the combined effects for chemicals having different
MOAs. The bad performance of IA to predict either ICmix or the
dose-response curve clearly results from the mixture studied here,
where we showed that most components act through the same
MOAs. At low doses, accumulation of the individual, low proba-
bilities derived for a high number of individual compounds pre-
sumably resulted in the dramatic overestimation of the
antagonistic effect.
5. Conclusions
We tested the AhR agonistic and antagonistic activities of 29
POPs shown to contaminate human blood, both in individual and
mixture forms. AhR transactivation activities in three reporter cell
lines exposed to the 29 POPs and themixtures were different due to
the species and tissue-specific responses. The predominant indi-
vidual activities of the POPs were AhR antagonism, as shown for 16
compounds out of 29 in rat DR-H4IIE cells, and for seven and five
compounds in human DR-T47-D and DR-Hep G2, respectively. Thetotal POP mixture already induced a significant AhR antagonistic
activity at concentrations of 125, 250, and 500 fold human blood
levels, respectively in DR-H4IIE, DR-T47-D and DR-Hep G2,
although each individual compound was present at concentrations
lower than its LOEC at these levels. Such blood levels of POPs could
realistically occur in food or environmental contamination in-
cidents or in highly exposed sub-populations. Chlorinated com-
pounds, among which PCB-118 and PCB-138 contributed 90% to the
activity of the total POP mixture, were the drivers for AhR antag-
onism in DR-H4IIE cells. Finally, CA and GCA proved to be good tools
to predict the mixed effect of the total POP mixture with only two-
fold underestimated IC50 and acceptable does response curves.
Hence, the compounds acted additively in the mixtures. Although
limitations remain to fully describe the effects of realistic mixtures
due to biological complexity, the predictions obtained using CA and
GCA seem suitable for establishing general regulatory guidelines
for mixture toxicity assessments. In addition, the data generated in
this study for individual compounds will be useful to predict the
effect of other complex mixtures constituted by these compounds.
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